(Press-News.org) DURHAM, N.C.— The largest comprehensive analysis of ClinicalTrials.gov finds that clinical trials are falling short of producing high-quality evidence needed to guide medical decision-making. The analysis, published today in JAMA, found the majority of clinical trials is small, and there are significant differences among methodical approaches, including randomizing, blinding and the use of data monitoring committees.
"Our analysis raises questions about the best methods for generating evidence, as well as the capacity of the clinical trials enterprise to supply sufficient amounts of high quality evidence to ensure confidence in guideline recommendations," said Robert Califf, M.D., first author of the paper, vice chancellor for clinical research at Duke University Medical Center, and director of the Duke Translational Medicine Institute.
The analysis was conducted by the Clinical Trials Transformation Initiative (CTTI), a public private partnership founded by the Food and Drug Administration (FDA) and Duke. It extends the usability of the data in ClinicalTrials.gov for research by placing the data through September 27, 2010 into a database structured to facilitate aggregate analysis. This publically accessible database facilitates the assessment of the clinical trials enterprise in a more comprehensive manner than ever before and enables the identification of trends by study type.
The National Library of Medicine (NLM), a part of the National Institutes of Health, developed and manages ClinicalTrials.gov. This site maintains a registry of past, current, and planned clinical research studies.
"Since 2007, the Food and Drug Administration Amendment Act has required registration of clinical trials, and the expanded scope and rigor of trial registration policies internationally is producing more complete data from around the world," stated Deborah Zarin, MD, director, ClinicalTrials.gov, and assistant director for clinical research projects, NLM. "We have amassed over 120,000 registered clinical trials. This rich repository of data has a lot to say about the national and international research portfolio."
This CTTI project was a collaborative effort by informaticians, statisticians and project managers from NLM, FDA and Duke. CTTI comprises more than 60 member organizations with the goal of identifying practices that will improve the quality and efficiency of clinical trials.
"Since the ClinicalTrials.gov registry contains studies sponsored by multiple entities, including government, industry, foundations and universities, CTTI leaders recognized that it might be a valuable source for benchmarking the state of the clinical trials enterprise," stated Judith Kramer, MD, executive director of CTTI.
The project goal was to produce an easily accessible database incorporating advances in informatics to permit a detailed characterization of the body of clinical research and facilitate analysis of groups of studies by therapeutic areas, by type of sponsor, by number of participants and by many other parameters.
"Analysis of the entire portfolio will enable the many entities in the clinical trials enterprise to examine their practices in comparison with others," says Califf. "For example, 96% of clinical trials have ≤1000 participants, and 62% have ≤ 100. While there are many excellent small clinical trials, these studies will not be able to inform patients, doctors and consumers about the choices they must make to prevent and treat disease."
The analysis showed heterogeneity in median trial size, with cardiovascular trials tending to be twice as large as those in oncology and trials in mental health falling in the middle. It also showed major differences in the use of randomization, blinding, and data monitoring committees, critical issues often used to judge the quality of evidence for medical decisions in clinical practice guidelines and systematic overviews.
"These results reinforce the importance of exploration, analysis and inspection of our clinical trials enterprise," said Rachel Behrman Sherman, MD, associate director for the Office of Medical Policy at the FDA's Center for Drug Evaluation and Research. "Generation of this evidence will contribute to our understanding of the number of studies in different phases of research, the therapeutic areas, and ways we can improve data collection about clinical trials, eventually improving the quality of clinical trials."
###
An analysis-ready copy of the ClinicalTrials.gov database is now available at
www.ctti-clinicaltrials.org. Specialists from numerous therapeutic areas are now scrutinizing the contents to better understand how the number and characteristics of clinical trials match the perceived needs of the research communities. This dataset will be useful for academic institutions and also for pharmaceutical and device companies to produce reports showing the completeness of their data entry compared to other institutions. Advocacy groups can chronicle the number and types of trials in their area of interest. Data quality is likely to improve as a function of the accountability fostered by this transparency.
The results of other projects conducted by CTTI can be found on the CTTI web site along with general information about the organization.
END
Ragsdale Liggett PLLC attorney Bill Pollock has been invited to join the prestigious Claims and Litigation Management Alliance. Membership is extended to select attorneys based only on nominations from current CLM fellows. The organization is comprised of thousands of insurance companies, corporations, corporate counsel, litigation and risk managers, claims professionals and attorneys who promote the highest standards of litigation management in the defense of clients.
Mr. Pollock is a litigation lawyer and partner at Ragsdale Liggett PLLC in Raleigh, North Carolina. ...
Vision and hearing are so crucial to our daily lives that any impairments usually become obvious to an affected person. Although a number of known genetic mutations can lead to hereditary defects in these senses, little is known about our sense of touch, where defects might be so subtle that they go unnoticed.
In the 1 May issue of the online, open-access journal PLoS Biology, Gary Lewin's laboratory at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin demonstrates that differences in touch sensitivity arise from genetic factors that can also be inherited. ...
A study in the May issue of the Cell Press journal Cell Metabolism appears to offer vindication for an approach to anti-aging drugs that has been at the center of heated scientific debate in recent years. The new findings show for the first time that the metabolic benefits of the red wine ingredient known as resveratrol evaporate in mice that lack the famed longevity gene SIRT1.
"Resveratrol improves the health of mice on a high-fat diet and increases life span," said David Sinclair of Harvard Medical School. The question was how.
Resveratrol is a dirty molecule, he ...
The search for great Canadian authors has begun! Have you written a book or novel? Do you dream about getting published but you don't know where to start?
This could be exactly what you need. Word Alive Press is launching their 9th Annual Free Publishing Contest and will select two winning Canadian manuscripts —one fiction and one non-fiction winner —to publish, market and distribute in both book and e-book format. The total prize package is worth over $10,000 ($5,000 for each winner).
Total Package
Screened and chosen by a judging committee that includes editors, ...
Researchers have discovered that a protein that transports sodium, potassium and chloride may hold clues to how glioblastoma, the most common and deadliest type of brain cancer, moves and invades nearby healthy brain tissue. The findings, reported 1 May in the online, open-access journal PLoS Biology, also suggest that a cheap FDA-approved drug already on the market could slow movement of glioblastoma cells.
"The biggest challenge in brain cancer is the migration of cancer cells. We can't control it," says study leader Alfredo Quinones-Hinojosa, M.D., an associate professor ...
Boston – Cardiothoracic surgeons and endocrinologists from Boston Medical Center (BMC) have found that among patients undergoing coronary artery bypass graft (CABG) surgery, achieving Surgical Care Improvement Project (SCIP) benchmarks for glycemic control may be irrelevant when perioperative continuous insulin infusion protocols are implemented. These findings will be presented at the Annual meeting of the American Association for Thoracic Surgery on May 1 in San Francisco, CA.
Currently, 40 percent of all patients undergoing CABG suffer from diabetes, and this number ...
Mims Distributing Company (http://www.mimsdist.com), a beer distributor that services a nine-county area in and around the Triangle, has announced that the company has been recognized as the Triangle Commercial Real Estate Women (TCREW) Champion in the Green and Sustainability category. The TCREW Champion Awards is an annual program that honors leaders, deals and projects in the Triangle commercial real estate industry. Mims Distributing partnered with Prime Building, HagerSmith PA, First Citizens Bank and Baker Renewable Energy to transform a pharmaceutical distribution ...
Los Angeles, CA (May 01, 2012) – Each time a release of radioactivity occurs, questions arise and debates unfold on the health risks at low doses—and still, just over a year after the disaster at the Fukushima Nuclear Power Station, unanswered questions and unsettled debates remain. Now a special issue of the Bulletin of the Atomic Scientists, published by SAGE, examines what is new about the debate over low-dose radiation risk, specifically focusing on areas of agreement and disagreement, including quantitative estimates of cancer risk as radiation dose increases, or what ...
Slacker or go-getter?
Everyone knows that people vary substantially in how hard they are willing to work, but the origin of these individual differences in the brain remains a mystery.
Now the veil has been pushed back by a new brain imaging study that has found an individual's willingness to work hard to earn money is strongly influenced by the chemistry in three specific areas of the brain. In addition to shedding new light on how the brain works, the research could have important implications for the treatment of attention-deficit disorder, depression, schizophrenia ...
Bold Endeavours announced launch of a new addition to its Big Easy Content Management System (CMS) - an integrated widget for adding videos on a webpage directly or add them from online video services such as YouTube and Vimeo. The new feature of CMS will allow placing videos with custom size player onto any area of a page quickly and would not require any special technical knowledge.
Although embedding video clips onto a webpage is not something new, however it is a complex procedure that most content management systems still suffer from. Especially it causes some ...
